Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.7%

5 terminated out of 134 trials

Success Rate

88.1%

+1.6% vs benchmark

Late-Stage Pipeline

25%

34 trials in Phase 3/4

Results Transparency

16%

6 of 37 completed with results

Key Signals

6 with results88% success

Data Visualizations

Phase Distribution

97Total
Not Applicable (48)
Early P 1 (1)
P 1 (1)
P 2 (13)
P 3 (14)
P 4 (20)

Trial Status

Unknown48
Completed37
Recruiting28
Active Not Recruiting6
Terminated5
Not Yet Recruiting4

Trial Success Rate

88.1%

Benchmark: 86.5%

Based on 37 completed trials

Clinical Trials (134)

Showing 20 of 20 trials
NCT04775914Not ApplicableRecruitingPrimary

STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance

NCT05462730Phase 2CompletedPrimary

Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction

NCT04217304Phase 2TerminatedPrimary

SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial

NCT05848674Not ApplicableCompletedPrimary

CArdiac Brief INtervention: A Feasibility Study to Promote Engagement With Cardiac Rehabilitation

NCT06040528Recruiting

Early Discharge Pathway Registry

NCT06174753Phase 3RecruitingPrimary

Dapagliflozin in STEMI

NCT05785897Not ApplicableRecruitingPrimary

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

NCT03858777Not ApplicableRecruiting

Cell Free DNA in Cardiac Sarcoidosis

NCT07195812Phase 4Not Yet RecruitingPrimary

Rivaroxaban for Slow Coronary Flow After PCI in STEMI

NCT06506448RecruitingPrimary

Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease

NCT06465303Phase 2RecruitingPrimary

A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)

NCT06227754Not ApplicableRecruitingPrimary

OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts

NCT03822975Not ApplicableCompletedPrimary

Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI

NCT03611725Not ApplicableCompleted

Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI

NCT06795035RecruitingPrimary

Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution

NCT07058857Not ApplicableRecruitingPrimary

The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocardial Infarction - A Single-Centre Randomized Control Trial

NCT06081803Phase 3Active Not RecruitingPrimary

Evolocumab in STEMI

NCT03778554Phase 4Active Not Recruiting

Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction

NCT03646357Phase 4Active Not Recruiting

BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function

NCT04939805Not ApplicableRecruitingPrimary

CRP Apheresis in STEMI

Scroll to load more

Research Network

Activity Timeline